Added to YB: 2026-09-22
Pitch date: 2026-09-20
BDX [bullish]
Becton, Dickinson and Company
-0.3%
current return
Author Info
No bio for this author
Company Info
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
Market Cap
$49.3B
Pitch Price
$181.25
Price Target
230.00 (+27%)
Dividend
2.32%
EV/EBITDA
10.35
P/E
31.07
EV/Sales
2.91
Sector
Health Care Equipment and Supplies
Category
special_situation
3 Under-the-Radar Guru Stocks - Becton, Dickinson and Company
BDX (monitor): Becton Dickinson was added to in Q4 2025 ahead of the completed Waters transaction; the Waters shares received were subsequently sold, while BDX contributed 2.79% to gross returns across 2025 and Q1 2026. The slimmed-down company has returned $3.1B to shareholders this year, and $225-$230 valuation markers imply 24%-27% upside from $180.94, contingent on consistently achieving mid-single-digit organic growth.
Read full article (4 min)